​

CASI Pharmaceuticals Ownership | Who Owns CASI Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

CASI Pharmaceuticals Ownership Summary

CASI Pharmaceuticals is owned by 11.14% institutional investors, and 88.86% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.13% of its assets in CASI Pharmaceuticals shares.

CASI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCASI Pharmaceuticals11.14%-88.86%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202217-1,520,573-6.39%117.82%8-11.11%4-
Sep 30, 2022176.25%1,624,416-11.20%116.60%9-43.75%4-
Jun 30, 202216-1,829,300-13-16---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index19.36K0.13%-
NT Quality SCC US Fund - L1.93K0.01%-180.00
NT Quality Small Cap Core1.93K0.01%-180.00
JNL/DFA US Small Cap A1.67K0.01%-
Dimensional US Small Cap CIT Class S1.03K0.01%-
Dimensional US Sm Company EUR Acc306.000.00%-
AZL® DFA US Small Cap142.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 06, 2022Huang James Buy$142.63K
Aug 31, 2022Huang James Buy$1.50K
Aug 24, 2022Huang James Buy$148.18K
Aug 19, 2022Huang James Buy$139.99K
Jun 15, 2022He Wei-Wu Chairman and CEOBuy$159.00K

Insider Transactions Trends

DateBuySell
2022 Q34-
2022 Q21-
2021 Q42-
2021 Q32-
2021 Q2--

CASI Ownership FAQ

Who Owns CASI Pharmaceuticals?

CASI Pharmaceuticals shareholders are primarily institutional investors at 11.14%, followed by 0% insiders and 0% retail investors. The average institutional ownership in CASI Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which CASI Pharmaceuticals falls below.

Does Blackrock own CASI Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CASI Pharmaceuticals.

Who is the top mutual fund holder of CASI Pharmaceuticals shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of CASI Pharmaceuticals shares, with 0.13% of its total shares outstanding invested in 19.36K CASI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools